Efficacy of a Multicomponent and Interdisciplinary Intervention on the Care Ability and Burden of Family Caregivers of People With Chronic Cardiocerebrovascular Diseases
NCT ID: NCT04645290
Last Updated: 2021-10-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
84 participants
INTERVENTIONAL
2021-03-08
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective: To determine the efficacy of a multicomponent and interdisciplinary intervention in B-Learning modality and a clinical simulation component on the ability to care and the burden on family caregivers of people with chronic cardio-cerebral vascular diseases in a condition of disability, of home care programs and home hospitalization in the cities of Bogotá and Bucaramanga.
Method: a study with an experimental design type double-blind controlled clinical trial (blinding of the people in charge of both initial and final measurements, and of those who perform the data analysis), with a mixed approach (QUAN + qual), with a group intervention and a control group. The study will be carried out in the cities of Bogotá and Bucaramanga. For the collection of the information, the characterization format of sociodemographic and clinical variables will be used for family caregivers and people in their care, the Ngozi Nkongho care skill instrument and the Zarit care burden instrument, mainly. Similarly, participant observation will be carried out in face-to-face workshops where the body dimension is addressed as a means for the recognition of family caregivers, their abilities and achievements. Likewise, focus groups will be held at the end of each workshop with the caregivers who wish to participate, until the theoretical saturation is achieved. The analysis of quantitative data will include descriptive statistics, inferential analysis, and a repeated measures ANOVA to assess the intragroup and intergroup effects of the response variables. The analysis of the qualitative data will be carried out using content analysis techniques (coding) and grounded theory (open and axial coding), and then carry out a data triagulation within the method (qualitative), to complement the understanding of the phenomenon. study and as validation. Finally, a methodological triangulation (between methods) will be carried out based on the general objective of the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group: Educational Intervention "KARER"
General objective of the intervention: Implement self-care strategies and care actions aimed at people facing chronic diseases with disabilities, applying knowledge, ability and attitudes that allow them to act in a timely manner, reducing the risk of complications, improving well-being and the quality of life of the person cared for and of himself. Through face-to-face, virtual interdisciplinary educational actions (B-learning) and with simulation support.
Intervention group: Educational Intervention "KARER"
Multicomponent and interdisciplinary intervention on the care ability and burden of family caregivers. It consists of:
Virtual componet
* Module 0: the introduction
* Module 1: called "Identifying my role as a caregiver"
* Module 2: called "Strategies to strengthen care"
* Module 3: called "Strengthening my caring skills"
Face-to-face componed - Two seasons of 4 hours each
Simulation component
\- One season of practices abilities of 4 hours.
Usual Care
The people assigned to this group will receive their own responses from the institution providing care services to which they belong. These instructions consist of: information on the disease process and treatment received from the medical group, information on assistance by the nursing group and finally, the administrative procedures carried out by social work.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention group: Educational Intervention "KARER"
Multicomponent and interdisciplinary intervention on the care ability and burden of family caregivers. It consists of:
Virtual componet
* Module 0: the introduction
* Module 1: called "Identifying my role as a caregiver"
* Module 2: called "Strategies to strengthen care"
* Module 3: called "Strengthening my caring skills"
Face-to-face componed - Two seasons of 4 hours each
Simulation component
\- One season of practices abilities of 4 hours.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be related to the person with cardiocerebrovascular disease in a condition of moderate to severe disability according to the Barthel scale.
* Having assumed the care of the person with a chronic illness in a condition of disability for a period greater than three months. (Note: if there is more than one family caregiver, the caregiver who has the longest stay in care and assistance will be selected).
* Know how to read and write.
* Have computer equipment and internet connectivity and a telephone
* Family caregivers residing in the cities of Bogotá and Bucaramanga.
* Accept voluntary participation in the study.
Exclusion Criteria
* Family caregivers of disabled people with cardiocerebrovascular disease, who are participating in other studies related to the topic of the research process.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundación Universitaria Sanitas
UNKNOWN
Universidad Nacional de Colombia
OTHER
Universidad de Santander
OTHER
Claudia Aristizábal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claudia Aristizábal
Coordinadora Unidad de Investigación
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Henry M Puerto Pedraza, RNs, MSc.
Role: PRINCIPAL_INVESTIGATOR
Fundación Universitaria Sanitas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundación Universitaria Sanitas
Bogotá, Bogota D.C., Colombia
Universidad Nacional de Colombia
Bogotá, Bogota D.C., Colombia
Universidad de Santander
Bucaramanga, Santander Department, Colombia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nkongho, N. O. (2003). The caring ability inventory. Measurement of nursing outcomes, 3, 184-198
Carrillo G GM, Sanchez-Herrera B, Barrera-Ortiz L. [Caring ability of family caregivers of children with cancer]. Rev Salud Publica (Bogota). 2015 May;17(3):394-403. doi: 10.15446/rsap.v17n3.32408. Spanish.
Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980 Dec;20(6):649-55. doi: 10.1093/geront/20.6.649. No abstract available.
Related Links
Access external resources that provide additional context or updates about the study.
EQ-5D User Guides
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEIFUS 389-19
Identifier Type: -
Identifier Source: org_study_id